Literature DB >> 15304467

Contagiousness of varicella in vaccinated cases: a household contact study.

Jane F Seward1, John X Zhang, Teresa J Maupin, Laurene Mascola, Aisha O Jumaan.   

Abstract

CONTEXT: Limited data are available on the contagiousness of vaccinated varicella cases.
OBJECTIVES: To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness. DESIGN, SETTING, AND PATIENTS: Population-based, active varicella surveillance project in a community of approximately 320,000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected. MAIN OUTCOME MEASURES: Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents.
RESULTS: A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%.
CONCLUSIONS: Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304467     DOI: 10.1001/jama.292.6.704

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  43 in total

1.  Comparing active and passive varicella surveillance in Philadelphia, 2005-2010: recommendations for the transition to nationwide passive varicella disease surveillance.

Authors:  Kendra Viner; Dana Perella; Adriana Lopez; Stephanie Bialek; Michael Nguyen; Niya Spells; Barbara Watson
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

2.  Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel.

Authors:  Jingzhou Liu; Beth F Kochin; Yonas I Tekle; Alison P Galvani
Journal:  J R Soc Interface       Date:  2011-06-01       Impact factor: 4.118

3.  An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Authors:  Margaret K Doll; Jennifer B Rosen; Stephanie R Bialek; Hiram Szeto; Christopher M Zimmerman
Journal:  Am J Public Health       Date:  2014-12-18       Impact factor: 9.308

4.  Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Alexia Campbell; Shainoor Ismail; Ben Tan
Journal:  Can Commun Dis Rep       Date:  2010-10-18

5.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

6.  Clinical characteristics and risk factors associated with breakthrough varicella during varicella outbreaks.

Authors:  Wei Qin; Xiao-Kang Xu; Yao Wang; Xiang-Mei Meng; Cheng-Wu Yang; Feng Xia; Hong Su
Journal:  Hum Vaccin Immunother       Date:  2020-03-02       Impact factor: 3.452

7.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

Review 8.  Pathogenesis and current approaches to control of varicella-zoster virus infections.

Authors:  Anne A Gershon; Michael D Gershon
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.